{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:15:49Z","timestamp":1761714949391,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019944","name":"Sanofi-Aventis Deutschland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.pcd.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T12:20:25Z","timestamp":1436098825000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials"],"prefix":"10.1016","volume":"10","author":[{"given":"Mark R.","family":"Lankisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Paule","family":"Dain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2015.05.003_bib0095","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2015.05.003_bib0100","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.05.003_bib0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/dmrr.733","article-title":"When basal insulin therapy in type 2 diabetes mellitus is not enough\u2014what next?","volume":"23","author":"Raccah","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.pcd.2015.05.003_bib0110","doi-asserted-by":"crossref","unstructured":"Intensive blood\u2013glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 352 (1998) 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.pcd.2015.05.003_bib0115","first-page":"245","article-title":"Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine","volume":"3","author":"Ulrich","year":"2007","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.pcd.2015.05.003_bib0120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/diacare.24.3.430","article-title":"The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes","volume":"24","author":"Chase","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.05.003_bib0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diabet.2012.08.010","article-title":"Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study","volume":"38","author":"Raccah","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2015.05.003_bib0130","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diacare.27.10.2363","article-title":"Insulin glulisine provides improved glycemic control in patients with type 2 diabetes","volume":"27","author":"Dailey","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.05.003_bib0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/dia.2011.0163","article-title":"Telecare provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine\u2014the ELEONOR study","volume":"14","author":"Del Prato","year":"2012","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.pcd.2015.05.003_bib0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1463-1326.2005.00563.x","article-title":"Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70\/30 (The 1-2-3 study)","volume":"8","author":"Garber","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.05.003_bib0145","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.05.003_bib0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4158\/EP10323.OR","article-title":"A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure","volume":"17","author":"Davidson","year":"2011","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.pcd.2015.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1463-1326.2008.00967.x","article-title":"Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs","volume":"10","author":"Lankisch","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1463-1326.2011.01459.x","article-title":"Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month \u2018proof-of-concept\u2019 study","volume":"13","author":"Owens","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.05.003_bib0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.pcd.2015.05.003_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/diacare.16.1.21","article-title":"Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial","volume":"16","author":"Henry","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.05.003_bib0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13300-010-0018-0","article-title":"Minimizing the risk of hypoglycemia with vildagliptin: clinical experience, mechanistic basis, and importance in type 2 diabetes management","volume":"2","author":"Dejager","year":"2011","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2015.05.003_bib0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1463-1326.2006.00665.x","article-title":"Does insulin detemir have a role in reducing risk of insulin-associated weight gain?","volume":"9","author":"Hermansen","year":"2007","journal-title":"Diabetes Obes. Metab."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181500073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199181500073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:55:08Z","timestamp":1761695708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175199181500073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S175199181500073X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2015.05.003","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}